SIRNAOMICS-B (02257) Grants Share Options and Restricted Share Units
SIRNAOMICS-B (02257) announced that on October 29, 2026, pursuant to the terms of the 2026 Share Option Scheme and the 2026 Restricted Share Unit Scheme, the Company granted approximately 893,600 share options to 25 option grantees and approximately 2,048,800 restricted share units to 27 restricted share unit grantees (excluding Dr. Pan Honghui), and conditionally granted 1,000,000 restricted share units to Dr. Pan Honghui, subject to acceptance by the option grantees, the restricted share unit grantees and Dr. Pan.
SIRNAOMICS-B (02257) announced that on October 29, 2026, pursuant to the terms of the 2026 Share Option Scheme and the 2026 Restricted Share Unit Scheme, the Company granted approximately 893,600 share options to 25 option grantees and approximately 2,048,800 restricted share units to 27 restricted share unit grantees (excluding Dr. Pan Honghui), and conditionally granted 1,000,000 restricted share units to Dr. Pan Honghui, subject to acceptance by the option grantees, the restricted share unit grantees and Dr. Pan.
Related Articles
SHANGHAI PECHEM (00338) reported gasoline sales revenue of RMB19.617 billion for the first three quarters.
160 HEALTH (02656) Appoints Wu Shixuan as Executive Director
.png)
Luxshare Precision Industry (02475) expects annual net profit attributable to shareholders of RMB19.09 billion to RMB19.92 billion, up about 15%-20% year on year.
SHANGHAI PECHEM (00338) reported gasoline sales revenue of RMB19.617 billion for the first three quarters.
160 HEALTH (02656) Appoints Wu Shixuan as Executive Director
Luxshare Precision Industry (02475) expects annual net profit attributable to shareholders of RMB19.09 billion to RMB19.92 billion, up about 15%-20% year on year.
